-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Abbvie (ABBV)
-
-
-
-
-
-
-
AbbVie submits vitiligo treatment application to FDA and EMA
-
-
-
-
-
-
-
UBS Reiterates Neutral Rating on Abbvie (ABBV)
-
-
-
-
-
-
-
Wolfe Research Downgrades Abbvie (ABBV) to Peerperform
-
-
-
-
-
-
-
Trump to announce prescription drug price agreements
-
-
-
-
-
-
-
DZ Bank Downgrades Abbvie (ABBV) to Hold
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $258 at BMO Capital
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

